An Enabling Technology for a Range of Applications
Q-SENS utilizes a novel, disruptive bio-detection technology using silicon biochips with embedded waveguides. Laser light injected into nano-scale waveguides produces detection that occurs at the intersection of two perpendicular sets of waveguides emitting the wavelength-shifted fluorescence and enabling the interrogation of specific sensing areas for the detection of up to 32 targets (i.e., biomarkers).
The Q-SENS Point-of-Need solution offers:
Sensitivity and specificity equal or better than central lab analyzers
Testing several biomarkers simultaneously in up to 32 sesnsing-wells
Small instrument footprint allows placement at the Point-of-Need
Small Sample (<10ul)
Detection in a blood drop or other small fluid sample and low reagent burden (~20ng Ab/test)
Real-time kinetics measure binding events as they occur
Minimally invasive, no filtering or washing steps, enabling self-testing by untrained individuals
Detection in 5-10 minutes
Low Target Costs
Highly affordable instrument (<$500) and consumables (<$5)
Results are instantly uploaded to a cloud server or smartphone, enhancing data harvesting and analysis capabilities, and allowing for easy monitoring and screening wherever needed.
Our proprietary platform has demonstrated exceptional performance on ~50 different assays (immunoassays and molecular) and is ready to be commercialized. We are working along with our dedicated partners to bring our solutions to the market.